Large Granular Lymphocytic Leukemia
2 clinical trials · Condition
◉ Watch Large Granular Lymphocytic Leukemia
| Record | Firm | Date |
|---|---|---|
| JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas (NCT06716658) | Institute of Hematology & Blood Diseases Hospital, China | 2024-12-25 |
| Effect of Cyclosporine Therapy on Gene Expression in Patients With Large Granular Lymphocyte Leukemia (NCT00363779) | National Cancer Institute (NCI) | 2006-06-01 |
Track Large Granular Lymphocytic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.